Global Diabetic Foot Ulcers and Pressure Ulcers Research Methodology Report: Incredible Possibilities Growth Challenges, Opportunities and Investment

Feasibility Diabetic foot ulcers and pressure ulcers are common medical problems affecting thousands of diabetics worldwide. These ulcers are often the result of poor treatment and care of the diabetes. The ulcerative process is initiated by a primary infection, which causes damage to the interior lining of the skin, or dermis. This process then causes an inflammation that is characteristic of a wound. The global diabetic foot ulcers and pressure ulcers industry is expected to grow at a high rate due to growing prevalence of diabetes.

Drivers:

Growing prevalence of diabetes is a primary factor driving growth of the global diabetic foot ulcers and pressure ulcers industry. For instance, according to the data of American Diabetes Association, it is projected that nearly 29 million people will be diagnosed with diabetes in the United States by 2050. Moreover, increasing geriatric population, adoption of novel therapeutics, and rising public awareness with regards to advanced biological therapies are also propelling the industry growth.

Get “Business Insights” Research Sample Copy of This Report @ https://www.worldwidemarketreports.com/sample/474570

Restraints:

High cost associated with ulcer management is the factor restraining growth of the global diabetic foot ulcers and pressure ulcers industry.

Regional Insights:

North America dominates the global diabetic foot ulcers and pressure ulcers industry due to high prevalence of diabetes, availability of biological therapies, and advanced healthcare and medical infrastructure in the region.

Asia Pacific is the fastest growing region in the global industry due to increasing incidences of diabetes and growing geriatric population in its emerging economies such as India. For instance, according to the United Nations Population Fund and Help Age India, the number of elderly people of age 60 years and above is likely to reach 173 million in India by 2026.

Competitive Section:

Key players of the global diabetic foot ulcers and pressure ulcers industry are Coloplast, 3M, Smith & Nephew, ConvaTec, B. Braun, Medtronic, Molnlycke, Medline, Acelity, BSN Medical, and Organogenesis.

In January 2020, ConvaTec released their COnvaMax, an absorber to treat diabetic foot ulcers.

In June 2020, Smith & Nephew announced publication of their study in Wound Management and Prevention stating the use of PICO.

By Type

Wound Care Dressings
Bio-actives
Wound Care Devices

By Application

Hospital Inpatient Settings
Hospital Outpatient Settings
Community Health Centers
Home Healthcare

Contact Us:

Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com

Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.

This release was published on openPR.